02.10.2018 06:20:14

Johnson & Johnson Closes Sale Of LifeScan Business To Platinum Equity

(RTTNews) - Johnson & Johnson (JNJ) announced that it has completed the divestiture of its LifeScan business to Platinum Equity for approximately $2.1 billion.

Headquartered in Chesterbrook, Pennsylvania and Zug, Switzerland, LifeScan, Inc., a maker of the OneTouch brand of products, generated net revenues of approximately $1.5 billion in 2017.

Johnson & Johnson said it will continue to serve those impacted by diabetes through innovative products, services and solutions from its Medical Device, Pharmaceuticals and Consumer businesses.

LifeScan also unveiled a new corporate logo and brand identity, in connection with transition to new ownership and its emergence as a standalone business.

Analysen zu Johnson & Johnsonmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Johnson & Johnson 138,22 0,52% Johnson & Johnson